NHAS
CRSP icon

Novo Holdings A/S’s CRISPR Therapeutics CRSP Stock Holding History

Novo Holdings A/S’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-223,317
Closed -$10.2M – 20
2018
Q1 		$10.2M Hold
223,317
– – 1.28% 12
2017
Q4 		$5.24M Hold
223,317
– – 0.74% 13
2017
Q3 		$3.99M Hold
223,317
– – 0.52% 16
2017
Q2 		$3.58M Hold
223,317
– – 0.43% 19
2017
Q1 		$4.86M Hold
223,317
– – 0.52% 20
2016
Q4 		$4.52M Buy
+223,317
New +$4.17M 0.43% 19

Other funds holding CRSP

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return